Ramsey, Ann Lockridge

Tara R. Rahemba is an associate in the Hartford office in the firm's Intellectual Property and FDA Practice Groups.   Ms. Rahemba's practice focuses on patent and regulatory issues unique to the pharmaceutical industry, including patent litigation and counseling.  She regularly litigates Paragraph IV patent infringement suits.  Ms. Rahemba has also been involved with petitioning FDA and in litigation against FDA relating to marketing exclusivities.  She also has experience litigating medical device patent infringement suits.

Prior to joining the firm, Ms. Rahemba worked for four and a half years as a formulation scientist at Pfizer, Inc., specializing in the development and manufacture of oral, solid controlled-release dosage forms.  As a laboratory scientist, Ms. Rahemba obtained extensive experience with Good Laboratory Practices and FDA compliance within the laboratory setting, and she also gained considerable experience in Good Manufacturing Practices while overseeing production of clinical and commercial supplies at various Pfizer facilities.  During her time at Pfizer, she also worked closely with clinical study managers and clinical research units, developing and reviewing protocols for both human and animal studies involving various new drug products. She has also assisted in the preparation of investigational new drug (IND) applications for FDA submission.

Ms. Rahemba's graduate research was in the field of tissue engineering of cartilage.  Her thesis work investigated the effects of serum supplementation and mechanical loading on the growth and viability of porcine cartilage explants in vitro.  She also replicated a therapeutic cartilage repair technique on cartilage explants and assessed the extent of repair observed in vitro.

While an undergraduate student, Ms. Rahemba worked for three summers at Regeneron Pharmaceuticals, Inc., a biotechnology company, in groups specializing in the development and optimization of fermentation and protein purification processes.